Dual-pharmacology bronchodilators for the treatment of COPD
JR Jacobsen, J Aiyar, S Hegde, AD Hughes… - New Drugs and Targets …, 2010 - karger.com
Frequently developed after years of smoking, chronic obstructive pulmonary disease
(COPD) is characterized by progressive air outflow limitation that is not fully reversible (1, 2) …
(COPD) is characterized by progressive air outflow limitation that is not fully reversible (1, 2) …
PHARMAC responds on long-acting inhalers for COPD
S Metcalfe, S Dougherty - The New Zealand Medical Journal …, 2005 - search.proquest.com
The uptake of tiotropium since the February listing has been low:* The prevalence of COPD--
and numbers of patients eligible for tiotropium treatment--can be difficult to quantify, 5, 6 with …
and numbers of patients eligible for tiotropium treatment--can be difficult to quantify, 5, 6 with …
[HTML][HTML] Comparaciones entre asociaciones de broncodilatadores de larga duración para la enfermedad pulmonar obstructiva crónica
B Alcázar-Navarrete, JL Lopez-Campos - Open Respiratory Archives, 2020 - Elsevier
A pesar de la aparición de numerosas revisiones sistemáticas y metaanálisis sobre el uso
de la doble terapia broncodilatadora para el tratamiento de la enfermedad pulmonar …
de la doble terapia broncodilatadora para el tratamiento de la enfermedad pulmonar …
Medical therapy for chronic obstructive pulmonary disease in 2007
EP Ingenito - Seminars in Thoracic and Cardiovascular Surgery, 2007 - Elsevier
Medical treatment for patients with stable chronic obstructive pulmonary disease (COPD)
has evolved significantly over the past 2 decades. Current World Health Organization …
has evolved significantly over the past 2 decades. Current World Health Organization …
Роль beta2-агонистов длительного действия в лечении хронической обструктивной болезни легких
АВ Аверьянов - Consilium Medicum, 2006 - elibrary.ru
Главным условием терапии хронической обструктивной болезни легких (ХОБЛ) на всех
стадиях заболевания является назначение бронхолитиков, не только облегчающих …
стадиях заболевания является назначение бронхолитиков, не только облегчающих …
Optimizing the management of chronic obstructive pulmonary disease: applying the GOLD strategy
A D'Urzo - Clinical Practice, 2013 - search.proquest.com
The goals for management of stable chronic obstructive pulmonary disease (COPD) as per
the latest Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013 revision …
the latest Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013 revision …
Cardiovascular safety of two bronchodilators' fixed-dose combination: indacaterol and glycopyrronium
J Kozielski - Advances in Respiratory Medicine, 2015 - mdpi.com
Combination therapy with anticholinergics and β 2-agonists should be used in COPD
patients after failure of previous monotherapy with one of these drugs. Synergistic effect of …
patients after failure of previous monotherapy with one of these drugs. Synergistic effect of …